{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 450864482
| image = Decitabine.svg

<!--Clinical data-->
| tradename = Dacogen
| Drugs.com = {{drugs.com|monograph|decitabine}}
| MedlinePlus = a608009
| DailyMedID = Decitabine
| licence_EU = yes
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_AU_comment = 
| pregnancy_US      = N
| pregnancy_US_comment = 
| pregnancy_category= 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = [[Intravenous_therapy|Intravenous]]
| ATC_prefix = L01
| ATC_suffix = BC08
| ATC_supplemental =  

| legal_US = Rx-only
| legal_status = Rx-only

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound = <1%
| metabolism =  
| elimination_half-life = 30分钟

<!--Identifiers-->
| IUPHAR_ligand = 6805
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 2353-33-5
| PubChem = 451668
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01262
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 397844
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 776B62CQ27
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03665
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 50131
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201129
| synonyms = 5-aza-2'-deoxycytidine

<!--Chemical data-->
| IUPAC_name = 4-Amino-1-(2-deoxy-β-<small>D</small>-erythro-pentofuranosyl)-1,3,5-triazin-2(1''H'')-one
| C=8 | H=12 | N=4 | O=4
| smiles = O=C1/N=C(\N=C/N1[C@@H]2O[C@@H]([C@@H](O)C2)CO)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H12N4O4/c9-7-10-3-12(8(15)11-7)6-1-4(14)5(2-13)16-6/h3-6,13-14H,1-2H2,(H2,9,11,15)/t4-,5+,6+/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = XAUDJQYHKZQPEU-KVQBGUIXSA-N
}}
'''地西他滨'''（[[国际非专利药品名称|INN]]：Decitabine），商品名'''达珂'''（{{lang|en|Dacogen}}），是一种[[胞苷|胞苷]][[类似物|类似物]]，也是[[阿扎胞苷|阿扎胞苷]]的一种脱氧类似物。与其类似物阿扎胞苷相似，地西他滨具有抑制[[DNA甲基化|DNA甲基化]]（低剂量）与[[DNA复制|DNA合成]]（高剂量）的效果<ref>{{Cite web|url=https://pubchem.ncbi.nlm.nih.gov/compound/451668|title=Decitabine|website=National Center for Biotechnology Information|access-date=2021-03-31|archive-date=2017-10-16|archive-url=https://web.archive.org/web/20171016214105/https://pubchem.ncbi.nlm.nih.gov/compound/451668}}</ref><ref name="ZhuQian2015">{{cite journal|last1=Zhu|first1=Wei|last2=Qian|first2=Jiaqi|title=Clinical Trials|year=2015|pages=525–568|doi=10.1016/B978-0-12-800206-3.00023-9}}</ref><ref name="RaynalIssa2016">{{cite journal|last1=Raynal|first1=Noël J.-M.|last2=Issa|first2=Jean-Pierre J.|title=DNA Methyltransferase Inhibitors|year=2016|pages=169–190|doi=10.1016/B978-0-12-802208-5.00007-2}}</ref>。目前临床上主要将地西他滨用于治疗[[骨髓增生异常综合征|骨髓增生异常综合征]]<ref name=EC-AML>{{cite news|title=EC Approves Marketing Authorization Of DACOGEN For Acute Myeloid Leukemia|url=http://www.rttnews.com/1973982/ec-approves-marketing-authorization-of-dacogen-for-acute-myeloid-leukemia.aspx?type=qf|access-date=2021-03-31|date=2012-09-28|archive-date=2017-09-14|archive-url=https://web.archive.org/web/20170914081701/http://www.rttnews.com/1973982/ec-approves-marketing-authorization-of-dacogen-for-acute-myeloid-leukemia.aspx?type=qf}}</ref>。

==参见==
*[[阿扎胞苷|阿扎胞苷]]

==参考文献==
{{reflist}}
{{化疗药物}}
{{Pharm-stub}}

[[Category:楊森製藥|Category:楊森製藥]]
[[Category:大塚製藥|Category:大塚製藥]]
[[Category:三嗪|Category:三嗪]]
[[Category:内酰胺|Category:内酰胺]]
[[Category:核苷|Category:核苷]]